menu
    • menu

    Company profile for Areteia Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Today, our team is focused on a single goal: To develop the first oral drug for eosinophilic asthma.Our global development team brings together experts from Knopp Biosciences, which previously developed dexpramipexole, and Population Health Partners, whose employees and executives led eight drug approvals involving 21 clinical trials and 91,000 patients worldwide in their earlier work at The Medicines Company.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Areteia TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    101 Glen Lennox Dr Suite 300 Chapel Hill, NC 27517
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://areteiatx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Areteia Posts Ph. 3 Asthma Win for Oral Rival to Biologic Drugs
    Areteia Posts Ph. 3 Asthma Win for Oral Rival to Biologic Drugs

    17 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250916566261/en/Areteia-Therapeutics-Announces-Positive-Topline-Results-from-the-First-Phase-III-Study-of-Oral-Dexpramipexole-in-Eosinophilic-Asthma

    BUSINESSWIRE
    17 Sep 2025
    Share Share
    Areteia Reports Positive Ph 3 Dexpramipexole Results In Asthma
    Areteia Reports Positive Ph 3 Dexpramipexole Results In Asthma

    16 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-16/areteia-therapeutics-announces-positive-topline-results-from-the-first-phase-iii-study-of-oral-dexpr

    PHARMAWEB
    16 Sep 2025
    Share Share
    Areteia Therapeutics Appoints Donald J. Hayden, Jr. and Ian F. Sm
    Areteia Therapeutics Appoints Donald J. Hayden, Jr. and Ian F. Sm

    26 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250326335483/en/Areteia-Therapeutics-Announces-Appointments-of-Donald-J.-Hayden-Jr.-and-Ian-F.-Smith-to-Its-Board-of-Directors

    BUSINESSWIRE
    26 Mar 2025
    Share Share
    Areteia To Present At 43rd J.P. Morgan Healthcare Conference Jan 14
    Areteia To Present At 43rd J.P. Morgan Healthcare Conference Jan 14

    09 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250109198891/en

    BUSINESSWIRE
    09 Jan 2025
    Share Share
    Areteia Announces Appointment of Daniel Becker To Board of Directors
    Areteia Announces Appointment of Daniel Becker To Board of Directors

    15 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240215803782/en

    BUSINESSWIRE
    15 Feb 2024
    Share Share
    Areteia Therapeutics Announces Additional $75MM in Series A Financing
    Areteia Therapeutics Announces Additional $75MM in Series A Financing

    13 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240213672000/en

    BUSINESSWIRE
    13 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search